Comparison of the effect of two balanced crystalloid intraoperative (iv) solutions ( plasmalyte vs sterofundin) on lactate levels during major cancer surgeries.
Not Applicable
Completed
- Conditions
- Health Condition 1: D099- Carcinoma in situ, unspecifiedHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2020/10/028716
- Lead Sponsor
- Rajiv Gandhi cancer institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients undergoing major onco-surgeries.
Exclusion Criteria
patients with significant renal, cardiac, or liver impairment, electrolyte imbalance in preoperative evaluation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie lactate level changes with Plasmalyte vs Sterofundin in oncological surgeries?
How do Plasmolyte and Sterofundin compare to standard crystalloid solutions in managing intraoperative metabolic acidosis in cancer patients?
Which biomarkers correlate with intraoperative lactate fluctuations during major cancer surgeries using balanced crystalloids?
What adverse events are associated with Plasmolyte and Sterofundin administration in major oncological procedures?
Are there combination therapies or alternative fluids that enhance metabolic stability during cancer surgeries compared to Plasmolyte and Sterofundin?